跳至主要内容
临床试验/NCT03193372
NCT03193372已完成不适用

A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea

LEO Pharma1 个研究点 分布在 1 个国家目标入组 2,200 人开始时间: 2017年7月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
LEO Pharma
入组人数
2,200
试验地点
1
主要终点
Demographics and clinical characteristics

研究概览

简要总结

To survey rosacea patients about their concerns, treatment satisfaction, and quality of life associated with their Finacea Foam treatment

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years of age
  • Diagnosis of rosacea by a medical professional
  • Currently using Finacea Foam as topical monotherapy for rosacea
  • Willing and able to provide voluntary, informed consent to participate in this study

排除标准

  • Use of any other topical treatment for rosacea at the time of enrollment

研究组 & 干预措施

Rosacea Concierge Program

Patients diagnosed with rosacea and currently receiving topical monotherapy with Finacea Foam

干预措施: Azelaic Acid (Finacea Foam, BAY39-6251) (Drug)

结局指标

主要结局

Demographics and clinical characteristics

时间窗: one-time survey in 2 week recruitment window

Collected patient demographics and characteristics are : * Year of birth * Gender * Insurance type

Rosacea-relevant comorbidities and complications

时间窗: one-time survey in 2 week recruitment window

Patient reported history of the following will be collected : * Blepharitis * Conjunctivitis * Corneal neovascularization/keratitis * Depression * Migraine

Rosacea subtype

时间窗: one-time survey in 2 week recruitment window

Patient reported diagnosis of the following will be collected: * Erythematotelangiectatic (facial redness) * Papulopustular (bumps and pimples) * Phymatous (enlargement of the nose) * Ocular (eye irritation) * Unknown

Past use of topical rosacea treatments

时间窗: one-time survey in 2 week recruitment window

Patient reported use of the following medications will be collected: * Metronidazole gel * Metronidazole cream * Metronidazole lotion * Metronidazole emulsion * Brimonidine tartrate gel

Patient concerns collected by Rosacea Treatment Preference Questionnaire

时间窗: one-time survey in 2 week recruitment window

Rosacea Treatment Preference Questionnaire is a survey to assess patient self-reported rosacea subtype and severity, and to evaluate the concerns that contribute to patient satisfaction/dissatisfaction, as well as treatment decisions with rosacea topical treatments

Treatment satisfaction assessed by Satisfaction with Medicines Questionnaire (SATMED-Q)

时间窗: one-time survey in 2 week recruitment window

SATMED-Q is a 17-question, validated, multidimensional generic questionnaire designed for use in patients with any chronic disease treated with medicines

Quality of life measured by Dermatology Life Quality Index (DLQI)

时间窗: one-time survey in 2 week recruitment window

DLQI is a widely used dermatology-related quality of life tool

次要结局

未报告次要终点

研究者

发起方
LEO Pharma
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Study of Patient Concerns and Treatment... | 临床试验